At the IGTP TODAY
The IGTP has organized a morning with the charity Fundació Salut Alta from Badalona that got everybody sticking together! The result of the experiment was 55 balls of coloured slime and a lot of happy faces!
Since 2007 the Immunopathology Group led by Dr Eva Martínez-Cáceres and Dr Cristian Ramo Tello at the IGTP has been working to develop a new treatment for autoimmune diseases, in this case for multiple sclerosis. To help their work in this task, Dr Martinez Cáceres has coordinated a COST project, a European network of scientists working on similar problems; the project concluded in 2017 and has now published its scientific report.
The Innovation in Respiratory Infections and Tuberculosis Diagnosis Group at the IGTP is partnering with Mind the Byte to work on the characterization and binding analysis of an immunostimulant known to trigger T-cell activation, which is crucial for the initiation and regulation of the immune response.
A study reveals the presence of proteins from hypnozoites, the latent phase of the parasite, in circulating extracellular vesicles. Proteins derived from the latent liver stage of Plasmodium vivax can be detected in small extracellular vesicles that circulate in blood, according to a study led by Hernando del Portillo, ICREA Research Professor at the IGTP and ISGlobal. The results pave the way for identifying patients with asymptomatic infections, an essential requirement to stop parasite transmission.
The Neurogenetics Research Group at the Germans Trias i Pujol Research Group, led by Dr Antoni Matilla has found the mutation and described the molecular mechanism that causes the sub-type of ataxia SCA37, which they first described in 2013. This find means that all the families with this alteration can be diagnosed before symptoms appear and that carriers can receive genetic counselling. It is also the first step on developing personalized therapies.
From Vilanova i la Geltrú to Brussels by bicycle. This challenge was accepted by the father of a boy with diabetes type 1 (DT1) and member of the charity DiabetesCero, and on the way he managed get Euro MPs interested in the disease. His amazing journey has produced a meeting to discuss the DT1 on 21-22 June; Dr Marta Vives-Pi, Group Leader of the Immunology of Diabetes Group of the IGTP was there.
The 10th Research Symposium of the Catalan Health Institute (ICS) and the 11th Research Symposium of the Primary Health Care Research Institute (IDIAP) Jordi Gol were held jointly on 7 June 2018. The central theme of the event was the use of large clinical data bases to carry out research to improve health.
The TV3 La Marató Foundation has published the results of the cancer research supported by Funds from the marathon campaign of 2012. Of the 79 research groups who participated in 42 projects financed by this edition of the programme three are from the IGTP.
Dr Katrin Beyer studies the molecular neuropathology of synucleinopathies. Here she tells us about her work and recent publications.
Researchers from the CIBERCV group at the Germans Trias i Pujol Research Institute (IGTP) have developed and compared two scaffolds, made by tissue engineering techniques.
